Adverse events30

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

21 to 30 of 30

Type	Event	Organ system	Group	Affected	At risk	Events
serious	Angina Pectoris	Cardiac disorders	Ambrisentan Verum	0	19	0
serious	Angina Pectoris	Cardiac disorders	Placebo	1	19	1
serious	Coronary artery disease	Cardiac disorders	Ambrisentan Verum	0	19	0
serious	Coronary artery disease	Cardiac disorders	Placebo	1	19	1
serious	Gastrointestinal infection	Gastrointestinal disorders	Ambrisentan Verum	0	19	0
serious	Gastrointestinal infection	Gastrointestinal disorders	Placebo	1	19	1
serious	Lymphangitis	Blood and lymphatic system disorders	Ambrisentan Verum	0	19	0
serious	Lymphangitis	Blood and lymphatic system disorders	Placebo	1	19	1
serious	Raynaud	Musculoskeletal and connective tissue disorders	Ambrisentan Verum	0	19	0
serious	Raynaud	Musculoskeletal and connective tissue disorders	Placebo	1	19	1

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02290613/events?page=2